DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Australia
  • /
  • Healthcare
Author Program NEWCreate Narrative
COH logo

Cochlear Limited Stock Price

ASX:COH Community·AU$8.8b Market Cap
  • 4 Narratives written by author
  • 1 Comments on narratives written by author
  • 103 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

COH Share Price Performance

AU$0
-300.59 (-100.00%)
​
AU$70.00
Fair Value
AU$0
-300.59 (-100.00%)
​
Price AU$0
Sat, 9 May 26
Fair ValueAU$70.00
Share Pricen/a

COH Community Narratives

RO
Robbo
Robbo's
Fair Value
·
Fair Value AU$70 96.5% overvalued intrinsic discount

Cochlear’s Crossroads: Temporary Setback or Structural Shift?

0users have liked this narrative
1users have commented on this narrative
12users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value AU$124.4 10.6% overvalued intrinsic discount

Aging Population Will Spur Cochlear Implant Adoption Worldwide

1users have liked this narrative
0users have commented on this narrative
44users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value AU$169.57 18.9% undervalued intrinsic discount

Hearing Health Tailwinds And Cloud Capabilities Will Support Multi Year Earnings Expansion

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
COH logo
Cochlear
96.5% overvalued intrinsic discount

Cochlear’s Crossroads: Temporary Setback or Structural Shift?

View narrative
RO
Robbo
Emerging Author
Robbo
Published 9 May
Read Narrative
COH logo
Cochlear
25.1% overvalued intrinsic discount

Cloud And R&D Investment Will Pressure Margins While Long Term Hearing Demand Supports Stability

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 3 Sep
Read Narrative
COH logo
Cochlear
18.9% undervalued intrinsic discount

Hearing Health Tailwinds And Cloud Capabilities Will Support Multi Year Earnings Expansion

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 18 Aug
Read Narrative
COH logo
Cochlear
10.6% overvalued intrinsic discount

Aging Population Will Spur Cochlear Implant Adoption Worldwide

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 18 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

RO
Robbo
COH logo

Cochlear’s Crossroads: Temporary Setback or Structural Shift?

Fair Value: AU$70 96.5% overvalued intrinsic discount
12 fair values setusers have set this as their fair value
1 commentusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
COH logo

COH: Softer Implant Volumes And Possible Investment Impairment Will Pressure Earnings

Fair Value: AU$110 25.1% overvalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
COH logo

COH: Softer Implant Volumes Will Set Up Future Earnings Rebound Potential

Fair Value: AU$169.57 18.9% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

2 Risks
2 Rewards
View Full Analysis

Cochlear Limited Key Details

AU$2.3b

Revenue

AU$688.0m

Cost of Revenue

AU$1.7b

Gross Profit

AU$1.5b

Other Expenses

AU$147.3m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
2.25
70.69%
6.27%
0%
View Full Analysis

About COH

Founded
1981
Employees
5400
CEO
Diggory Howitt
WebsiteView website
www.cochlear.com

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Recent COH News & Updates

User avatar
Narrative Update • Sep 03

COH: Softer Implant Volumes And Possible Investment Impairment Will Pressure Earnings

Cochlear's analyst fair value has been lifted from A$100 to A$110 as analysts factor in updated Street targets, including Citi's higher A$140 price target and recent mixed views on near term implant demand and reimbursement related volume delays. Analyst Commentary Recent Street commentary on Cochlear highlights a more balanced mix of views, with some analysts turning cautious on near term execution and growth risks despite higher published fair values and selected price target revisions.

Recent updates

No updates

Cochlear Limited Competitors

SIG logo

Sigma Healthcare

Symbol: ASX:SIG
Market cap: AU$30.7b
PME logo

Pro Medicus

Symbol: ASX:PME
Market cap: AU$17.4b
RHC logo

Ramsay Health Care

Symbol: ASX:RHC
Market cap: AU$12.3b
SHL logo

Sonic Healthcare

Symbol: ASX:SHL
Market cap: AU$9.6b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide